This protocol is judged by an institutional critique board, an independent group that opinions any clinical trials involving people. If a study involves a Timetable I drug, once the board approves the protocol as moral, the scientists need to submit an application for an investigational new drug (IND) number through the FDA.Therefore, medicine wil